Poultry Pharmaceuticals Market Size, Share & Trends Analysis Report By Product Type (Drugs (Vetrimoxin, Other drug products), Vaccines (Innovax, Nobilis, Poulvac, Other vaccine products), Feed Additives (VIGOSINE, Amnovit, Other feed additives)), By Animal Type, By Region, And By Segment Forecasts, 2023-2031.

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Poultry Pharmaceuticals Market Snapshot Chapter 4. Global Poultry Pharmaceuticals Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis 5.1. By Product Type, & Market Share, 2023 & 2031 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product Type: 5.2.1. Drugs 5.2.1.1. VETRIMOXIN 5.2.1.2. Other Drug Products 5.2.2. Vaccines 5.2.2.1. INNOVAX 5.2.2.2. NOBILIS 5.2.2.3. Poulvac 5.2.2.4. Other Vaccine Products 5.2.3. Feed Additives 5.2.3.1. VIGOSINE 5.2.3.2. Amnovit 5.2.3.3. Other Feed Additives Chapter 6. Market Segmentation 2: By Animal Type Estimates & Trend Analysis 6.1. By Animal Type & Market Share, 2023 & 2031 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Animal Type: 6.2.1. Chicken 6.2.2. Turkey 6.2.3. Duck 6.2.4. Goose 6.2.5. Others 7.1. Global Poultry Pharmaceuticals Market , Regional Snapshot 2023 & 2031 7.2. North America Chapter 7. Poultry Pharmaceuticals Market Segmentation 3: Regional Estimates & Trend Analysis 7.2.1. North America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 7.2.1.1. US 7.2.1.2. Canada 7.2.2. North America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031 7.2.3. North America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product type, 2024-2031 7.3. Europe 7.3.1. Europe Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 7.3.1.1. Germany 7.3.1.2. U.K. 7.3.1.3. France 7.3.1.4. Italy 7.3.1.5. Spain 7.3.1.6. Rest of Europe 7.3.2. Europe Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031 7.3.3. Europe Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product type, 2024-2031 7.4. Asia Pacific 7.4.1. Asia Pacific Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 7.4.1.1. India 7.4.1.2. China 7.4.1.3. Japan 7.4.1.4. Australia 7.4.1.5. South Korea 7.4.1.6. Hong Kong 7.4.1.7. Southeast Asia 7.4.1.8. Rest of Asia Pacific 7.4.2. Asia Pacific Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031 7.4.3. Asia Pacific Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts By Product type, 2024-2031 7.5. Latin America 7.5.1. Latin America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 7.5.1.1. Brazil 7.5.1.2. Mexico 7.5.1.3. Rest of Latin America 7.5.2. Latin America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031 7.5.3. Latin America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product type, 2024-2031 7.6. Middle East & Africa 7.6.1. Middle East & Africa Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 7.6.1.1. GCC Countries 7.6.1.2. Israel 7.6.1.3. South Africa 7.6.1.4. Rest of Middle East and Africa 7.6.2. Middle East & Africa Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031 7.6.3. Middle East & Africa Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product type, 2024-2031 Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Aervoe Industries Inc. 8.2.1.1. Business Overview 8.2.1.2. Key Product/Service Overview 8.2.1.3. Financial Performance 8.2.1.4. Geographical Presence 8.2.1.5. Recent Developments with Business Strategy 8.2.2. Bayer AG, 8.2.3. Bimeda 8.2.4. Ceva Sante Animale 8.2.5. Elanco Animal Health (Eli Lilly and Company) 8.2.6. Merck Animal Health 8.2.7. Merial Animal Health (Sanofi) 8.2.8. Virbac 8.2.9. Boehringer Ingelheim 8.2.10. Zoetis, Inc. 8.2.11. Pacific GeneTech 8.2.12. Avivagen Inc. 8.2.13. Hester Biosciences Limited 8.2.14. Venkys India 8.2.15. Calier 8.2.16. KM Biologics 8.2.17. Others